Catalyst Wire Dossier Catalyst Wire Dossier

Daclatasvir (Daklinza)

daclatasvir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Daclatasvir (Daklinza), covering 2017-10-10 to 2017-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4

See pricing